Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate dose exploration for general anesthesia in short elective adult surgery
ChiCTR2100053258Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in None (3 arms), sponsored by Tongji Hospital. Primary endpoints: Incidence of hypotension during induction and maintenance and Sedation success rate during induction and maintenance. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100053258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053258.